The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADICET BIO INC | COM | 007002108 | 1,804,328 | 767,799 | SH | SOLE | 767,799 | 0 | 0 | ||
AEROVATE THERAPEUTICS INC | COM | 008064107 | 11,936,965 | 403,685 | SH | SOLE | 403,685 | 0 | 0 | ||
AKERO THERAPEUTICS INC | COM | 00973Y108 | 8,588,400 | 340,000 | SH | SOLE | 340,000 | 0 | 0 | ||
ALLOGENE THERAPEUTICS INC | COM | 019770106 | 3,218,400 | 720,000 | SH | SOLE | 720,000 | 0 | 0 | ||
ALLOVIR INC | COM | 019818103 | 3,170,580 | 4,200,000 | SH | SOLE | 4,200,000 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 49,205,132 | 1,241,300 | SH | SOLE | 1,241,300 | 0 | 0 | ||
AN2 THERAPEUTICS INC | COM | 037326105 | 3,584,750 | 1,103,000 | SH | SOLE | 1,103,000 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 3,715,800 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | ||
ANNEXON INC | COM | 03589W102 | 14,698,500 | 2,050,000 | SH | SOLE | 2,050,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 11,756,000 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 164,994,284 | 2,806,980 | SH | SOLE | 2,806,980 | 0 | 0 | ||
ARRIVENT BIOPHARMA INC | COM | 04272N102 | 34,716,911 | 1,943,836 | SH | SOLE | 1,943,836 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 7,150,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
ATYR PHARMA INC | COM NEW | 002120202 | 1,365,000 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 1,122,880 | 176,000 | SH | SOLE | 176,000 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 21,334,800 | 690,000 | SH | SOLE | 690,000 | 0 | 0 | ||
CABALETTA BIO INC | COM | 12674W109 | 887,120 | 52,000 | SH | SOLE | 52,000 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 23,279,130 | 2,060,100 | SH | SOLE | 2,060,100 | 0 | 0 | ||
CENTURY THERAPEUTICS INC | COM | 15673T100 | 2,257,200 | 540,000 | SH | SOLE | 540,000 | 0 | 0 | ||
CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | 15,892,200 | 405,000 | SH | SOLE | 405,000 | 0 | 0 | ||
CYBIN INC | COM | 23256X100 | 7,693,023 | 18,604,650 | SH | SOLE | 18,604,650 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 13,601,340 | 194,000 | SH | SOLE | 194,000 | 0 | 0 | ||
DIANTHUS THERAPEUTICS INC | COM | 252828108 | 41,420,010 | 1,380,667 | SH | SOLE | 1,380,667 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 35,287,209 | 1,242,945 | SH | SOLE | 1,242,945 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 22,602,707 | 1,093,503 | SH | SOLE | 1,093,503 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 3,822,672 | 520,800 | SH | SOLE | 520,800 | 0 | 0 | ||
GLYCOMIMETICS INC | COM | 38000Q102 | 9,000,000 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 10,841,702 | 9,187,883 | SH | SOLE | 9,187,883 | 0 | 0 | ||
HELIX ACQUISITION CORP II | CL A ORD SHS | G4444H101 | 2,587,500 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 8,829,968 | 273,289 | SH | SOLE | 273,289 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 30,928,200 | 1,140,000 | SH | SOLE | 1,140,000 | 0 | 0 | ||
JASPER THERAPEUTICS INC | COM NEW | 471871202 | 14,703,811 | 500,811 | SH | SOLE | 500,811 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 4,480,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
MIND MEDICINE MINDMED INC | COM NEW | 60255C885 | 20,238,200 | 2,153,000 | SH | SOLE | 2,153,000 | 0 | 0 | ||
MINERALYS THERAPEUTICS INC | COM | 603170101 | 7,100,500 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 9,649,200 | 408,000 | SH | SOLE | 408,000 | 0 | 0 | ||
NKARTA INC | COM | 65487U108 | 2,594,400 | 240,000 | SH | SOLE | 240,000 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 5,004,527 | 1,374,870 | SH | SOLE | 1,374,870 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 22,067,500 | 2,425,000 | SH | SOLE | 2,425,000 | 0 | 0 | ||
PEPGEN INC | COM | 713317105 | 5,528,920 | 376,117 | SH | SOLE | 376,117 | 0 | 0 | ||
PERSPECTIVE THERAPEUTICS INC | COM | 46489V104 | 17,514,922 | 14,718,422 | SH | SOLE | 14,718,422 | 0 | 0 | ||
PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 4,832,100 | 455,000 | SH | SOLE | 455,000 | 0 | 0 | ||
POSEIDA THERAPEUTICS INC | COM | 73730P108 | 2,347,840 | 736,000 | SH | SOLE | 736,000 | 0 | 0 | ||
PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | 15,865,200 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 2,622,160 | 292,000 | SH | SOLE | 292,000 | 0 | 0 | ||
RENEO PHARMACEUTICALS INC | COM | 75974E103 | 3,735,000 | 2,250,000 | SH | SOLE | 2,250,000 | 0 | 0 | ||
SANA BIOTECHNOLOGY INC | COM | 799566104 | 3,608,000 | 360,800 | SH | SOLE | 360,800 | 0 | 0 | ||
SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 6,804,000 | 315,000 | SH | SOLE | 315,000 | 0 | 0 | ||
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 21,713,047 | 506,604 | SH | SOLE | 506,604 | 0 | 0 | ||
TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 8,696,100 | 3,030,000 | SH | SOLE | 3,030,000 | 0 | 0 | ||
TENAYA THERAPEUTICS INC | COM | 87990A106 | 14,926,420 | 2,854,000 | SH | SOLE | 2,854,000 | 0 | 0 | ||
TERNS PHARMACEUTICALS INC | COM | 880881107 | 4,100,000 | 625,000 | SH | SOLE | 625,000 | 0 | 0 | ||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 8,256,127 | 1,501,114 | SH | SOLE | 1,501,114 | 0 | 0 | ||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 38,117,210 | 2,369,000 | SH | SOLE | 2,369,000 | 0 | 0 | ||
VERU INC | COM | 92536C103 | 2,660,380 | 3,800,000 | SH | SOLE | 3,800,000 | 0 | 0 | ||
VINCERX PHARMA INC | COM NEW | 92731L106 | 5,060,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 10,856,200 | 620,000 | SH | SOLE | 620,000 | 0 | 0 |